梅州白带水状有异味(梅州割双眼皮一般要多少价格) (今日更新中)

BEIJING, Feb. 10 (Xinhua) -- The Chinese currency, or the yuan, on Thursday rose to a fresh high of 6.5849 against the U.S. dollar, according to the China Foreign Exchange Trading System.The central parity rate of the yuan, or RMB, was 1 basis point higher than the previous record of 6.585 set on Feb. 9, the previous trading day.The central parity rate has risen against the dollar for a three consecutive trading days.China's central bank announced on June 19 last year that it would further reform the yuan exchange rate formation mechanism to improve its flexibility.On China's foreign exchange spot market, the yuan can rise or fall 0.5 percent from the central parity rate each trading day.The central parity rate of the RMB against the U.S. dollar is based on a weighted average of prices before the opening of the market each business day.

BEIJING, May 16 (Xinhuanet) -- NASA is close to deciding on a landing site for its Mars rover Curiosity mission by narrowing the choices to four, media reports said Monday.Scientists in the close-knit Mars research community get one last chance to make their case this week when they gather before the "judges" — the team running the 2.5 billion U.S. dollar mission that will soon suggest a landing site to NASA, the ultimate decider."All four of these places are compelling places on Mars to study. There's not a loser among them," said landing site scientist Matt Golombek of the NASA Jet Propulsion Laboratory, one of the meeting's leaders.The mission will use rover Curiosity to study whether a selected area will have environmental conditions suitable for life and for preserving evidence about whether extraterrestial life has existed.Being nuclear-powered, the rover cannot go to a location that has either water or ice within one meter of the surface.The size of a mini Cooper, Curiosity is scheduled to launch in late November after a two-year delay.

LOS ANGELES, March 3 (Xinhua) -- More and more American adults are suffering from a decline in overall sleep duration, the U.S. Centers for Disease Control and Prevention (CDC) said on Thursday.It's recommended that adults should sleep seven to nine hours a night to maintain good health, but more than one-third of Americans do not meet that requirement, according to the CDC.Insufficient sleep poses a long-term heath threat and impairs work performance and the ability to drive safely, the CDC said.Chronic sleep loss also is associated with obesity, increased risk of death and other health problems, according to the CDC."Over the last 20 years there has been a decline in overall sleep duration in adults," said Lela McKnight-Eily, a clinical psychologist and epidemiologist at the CDC's National Center for Chronic Disease Prevention."Within our culture there seems to be a belief that sleep isn't a part of overall essential health," she said.McKnight-Eily and her colleagues studied the sleep habits of 74,571 adults in 12 states, 35.3 percent reported sleeping less than seven hours.In addition, 48 percent reported snoring, 37.9 percent said they fell asleep at least once during the day the previous month and 4.7 percent admitted to falling asleep at the wheel at least once.Drowsiness or nodding off while driving accounts for 1,550 deaths and 40,000 injuries a year, according to the U.S. Department of Transportation.To get enough sleep, Americans have to change lifestyle habits, including longer workdays and late nights on the computer, McKnight-Eily said, noting that too much screen time paring away much-needed sleep time.

WASHINGTON, May 20 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved Sutent to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body.Neuroendocrine tumors found in the pancreas are slow-growing and rare. It is estimated that there are fewer than 1,000 new cases in the United States each year.This is the second new approval by the FDA to treat patients with this disease. On May 5, the agency approved Afinitor."FDA believes it is important to provide cancer patients with as many treatment options as possible," said Richard Pazdur, director of the Office of Oncology Drug Products in the FDA's Center for Drug Evaluation and Research. "The agency is committed to working with companies to bring innovative new therapies to the market and encourages companies to continue exploring additional uses for approved products."The safety and effectiveness of Sutent was established in a single study of 171 patients with metastatic (late-stage) or locally advanced (disease that could not be removed with surgery) disease who received Sutent or a placebo (sugar pill). The study was designed to measure the length of time a patient lived before their disease spread or worsened (progression-free survival).Results from the study demonstrate that Sutent provided benefit to patients by prolonging the median length of time they lived without the cancer spreading or worsening to 10.2 months compared to 5.4 months for patients who received placebo.In patients treated with Sutent for neuroendocrine pancreatic tumors, the most commonly reported side effects included diarrhea, nausea, vomiting, fatigue, anorexia, high blood pressure, energy loss, stomach pain, changes in hair color, inflammation of the mouth, and a decrease in infection-fighting white blood cells.Sutent is marketed by New York City-based Pfizer.

BEIJING, Jan. 24 (Xinhua) -- China's top economic planner said Monday that price supervision and control measures have achieved steady progress with 2010's Consumer Price Index, slightly exceeding the target ceiling by 0.3 percentage points to hit 3.3 percent.To rein in soaring commodities prices, joint efforts have been made to manage inflation expectations, promote production, ensure supplies and strengthen price supervision in 2010, said the National Development and Reform Commission (NDRC) in an online statement.Prices of necessities accelerating during the second half of 2010 have been contained with vegetable prices down 9.4 percent in December from the previous month last year, it said.Further, prices of edible vegetable, pork, egg, sugar,liquefied petroleum gas and clothing also decreased significantly in December month on month, the statement said.To cope with rising prices beginning in July 2010, especially prices of basic supplies, the central government promptly introduced joint inter-ministerial meetings to discuss price controls among 17 ministries and ordered local governments to establish the same mechanism, it noted.Local governments have worked on improving agricultural facilities, especially in south China's Hainan province, to increase vegetables supplies for northern cities over the past year, the statement said.The statement forecasts that vegetable planting areas in 2010's autumn and winter will increase 530,000 hectares year on year, sending output to 337 million tonnes.To ensure production and supply, departments have worked to reduce fertilizer exports and promote links between production areas and purchasing areas, it added.Further, relevant authorities also took measures to stabilize prices of electricity and coal, and to ensure smooth transportation of agricultural produce.Authorities also granted temporary subsidies and raised basic wages and minimum living subsidies for urban and rural residents to guarantee people's daily life.

来源：资阳报